Genomics

Sequencing and interpretation, from whole genome sequencing to solid tumors, from RNA sequencing to liquid biopsy. Our proprietary pipelines offer precise sequencing and interpretation to research organizations and clinics worldwide.

Diagnostic

With over 3 million COVID-19 samples analyzed, 30 thousands whole genomes sequenced in our clinical lab, 500 thousands reports generated, we provide governments and clinics with effective end-to-end solutions for diagnostics at scale.

pharma

Our platform achieves a more effective, less risky, drug repurposing for genetic diseases by leveraging our whole genome database and a graph neural network approach to drug discovery.

Software

Our Immensa Genomic Interpretation Software offers more precise and faster analysis of complex genomic data, using machine learning and a continuous feedback loop from our database and the clinical lab.

ABOUT US

We deploy genomic applications that have an impact in people’s lives, turning healthcare data into solutions for patients and doctors, leveraging our database and machine learning algorithms.

Our genomic-data-driven approach to diagnostics and therapeutic development impacts research and clinical decisions, giving mission critical tools and reports for healthcare professionals.

Enabling genomic-driven prevention
Oncology: solid tumor and liquid biopsy solutions
3 million COVID-19 samples analyzed
ISO13485
Unparalleled experience with whole genome sequencing
Previous
Next

PLATFORM

Turning genomic data into patient solutions

Diagnostics

End-to-end solutions for rare diseases, oncology, infectious diseases and women’s health.

Pharma

GWAS-driven drug discovery platform for effective drug repurposing for complex pathways.

Sequencing

Next generation sequencing at scale, run on our proprietary software platform for customized sequencing services and premium turnaround time.

Software

Clinically validated, Immensa proprietary software using machine learning for the analysis and interpretation of genomic data at scale.

Lab Integration

Software fully integrated with the clinical lab, using real-time data and machine learning to drive effectiveness and standardization in the lab.

Database

Proprietary whole genome database with statistically significant datasets across different continents and disease areas.

INDIVIDUALS

Our services designed for your health.

Brand X

Lorem ipsum dolor sit amet consectetur adipiscing elit.

This is the heading

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here

Brand Z

Lorem ipsum dolor sit amet consectetur adipiscing elit.

This is the heading

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here

Brand Y

Lorem ipsum dolor sit amet consectetur adipiscing elit.

This is the heading

Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here

PARTNERS

Genomic Research Clients

NEWS

Corporate

Dante Labs announces appointments of Paul Jones, Simon Partridge and Christian Bourne to turbo-charge global population genomics programmes

Paul Jones, Simon Partridge and Christian Bourne, previously from Illumina and Genomics England, have joined Dante Labs in its new Cambridge, UK office to spearhead its ground-breaking global population genomics offer CAMBRIDGE, United Kingdom, May 11, 2021 — Dante Labs today announced Paul Jones, Simon Partridge and Christian Bourne have joined the Company’s Executive Team …

A new approach to your health.

0 x
Genomic Sequences
0 %
Passing Filter Ratio
0 %
Q30 Score
0
Gigabases per run

Contact us